MT7, a novel compound from a combinatorial library, arrests mitosis via inhibiting the polymerization of microtubules-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MT7, a novel compound from a combinatorial library, arrests mitosis via inhibiting the polymerization of microtubules

Published:2009-08-25 Issue:6 Volume:28 Page:715-728
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Zhang Zhixiang,Meng Tao,He Jingxue,Li Ming,Tong Lin-Jiang,Xiong Bing,Lin Liping,Shen Jingkang,Miao Ze-Hong,Ding Jian

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-009-9303-z.pdf

Reference56 articles.

1. Sherr CJ (1996) Cancer Cell Cycles. Science 274:1672–1677

2. Castedo M, Perfettini J-L, Roumier T et al (2004) Cell death by mitotic catastrophe: a molecular definition. Oncogene 23:2825–2837

3. Wood KW (2001) Past and future of the mitotic spindle as an oncology target. Curr. Opin. Pharmacol. 1:370–377

4. Jackson JR, Patrick DR, Dar MM et al (2007) Targeted anti-mitotic therapies: can we improve on tubulin agents? Nat Rev Cancer 7:107–117

5. Jordan MA, Wilson L (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer 4:253–265

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Efficient Synthesis of Benzimidazole‐pyrazines via the Sequential Ugi/Hydroamination/Cyclization Reactions;ChemistrySelect;2023-08-16

2. One‐pot synthesis of benzimidazole‐pyrazines and their anticancer activities;Journal of Heterocyclic Chemistry;2019-11-07

3. The Structure of MT189-Tubulin Complex Provides Insights into Drug Design;Letters in Drug Design & Discovery;2019-09-11

4. Discovery of thalicthuberine as a novel antimitotic agent from nature that disrupts microtubule dynamics and induces apoptosis in prostate cancer cells;Cell Cycle;2018-03-04

5. New microtubulin inhibitor MT189 suppresses angiogenesis via the JNK-VEGF/VEGFR2 signaling axis;Cancer Letters;2018-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3